Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-061847
Filing Date
2008-03-20
Accepted
2008-03-20 16:02:30
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2007 d10k.htm 10-K 945121
2 THIRD AMENDMENT TO LEASE AGREEMENT dex1027.htm EX-10.27 15190
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1380
4 CERTIFICATION OF PEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 8443
5 CERTIFICATION OF PFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 8600
6 CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 5695
7 GRAPHIC g63210g16j59.jpg GRAPHIC 40395
8 GRAPHIC g63210img001.jpg GRAPHIC 7466
  Complete submission text file 0001193125-08-061847.txt   1052059
Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Filer) CIK: 0001401923 (see all company filings)

EIN.: 200507047 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-33719 | Film No.: 08702595
SIC: 2834 Pharmaceutical Preparations